Expert Review of Anticancer Therapy, Volume 24, Issue 1-2 (2024)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Anticancer Therapy, Volume 24, Issue 1-2 (2024)

See all volumes and issues
Volume 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Key Paper Evaluation

Review Article
NECTIN-4 targeted theranostics for urothelial cancer: getting ready for primetime?
Luca Filippi & Orazio Schillaci
Pages: 1-4
Published online: 26 Nov 2023
AbstractforNECTIN-4 targeted theranostics for urothelial cancer: getting ready for primetime? | Full Text | References | PDF (696.2 KB) | EPUB
  • 240 Views
  • 0 CrossRef citations
  • 0Altmetric

Special Report

Report
Ifosfamide-induced nephrotoxicity in oncological patients
Juan Eduardo Quiroz-Aldave, María Del Carmen Durand-Vásquez, Freddy Shanner Chávez-Vásquez, Alexandra Noelia Rodríguez-Angulo, Sonia Elizabeth Gonzáles-Saldaña, Carlos César Alcalde-Loyola, Julia Cristina Coronado-Arroyo, Francisca Elena Zavaleta-Gutiérrez, Luis Alberto Concepción-Urteaga, Juan Carlos Haro-Varas & Marcio José Concepción-Zavaleta
Pages: 5-14
Published online: 01 Dec 2023
AbstractforIfosfamide-induced nephrotoxicity in oncological patients | Full Text | References | PDF (2.6 MB) | EPUB | Supplemental
  • 155 Views
  • 0 CrossRef citations
  • 0Altmetric
Report
Considerations regarding maintenance therapy for acute myeloid leukemia in remission
Gary J. Schiller & Vlad Kustanovich
Pages: 15-20
Published online: 22 Jan 2024
AbstractforConsiderations regarding maintenance therapy for acute myeloid leukemia in remission | Full Text | References | PDF (283.2 KB) | EPUB
  • 518 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review

Review Article
Cancer immunotherapy efficacy and machine learning
Yuting Fang, Xiaozhong Chen & Caineng Cao
Pages: 21-28
Published online: 02 Feb 2024
AbstractforCancer immunotherapy efficacy and machine learning | Full Text | References | PDF (344 KB) | EPUB
  • 176 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Circadian rhythm-based cancer therapy in randomised clinical trials
Loredana G. Marcu
Pages: 29-39
Published online: 25 Dec 2023
AbstractforCircadian rhythm-based cancer therapy in randomised clinical trials | Full Text | References | PDF (886 KB) | EPUB
  • 210 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma
Amrita Goyal & Francine Foss
Pages: 41-58
Published online: 26 Jan 2024
AbstractforAllogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma | Full Text | References | PDF (1.9 MB) | EPUB
  • 139 Views
  • 0 CrossRef citations
  • 0Altmetric

Meta-analysis

Review Article
Comparison of poly (ADP-ribose) polymerase inhibitors (PARPis) as maintenance therapy for newly-diagnosed and platinum-sensitive recurrent ovarian cancer with BRCA mutational status: a systematic review and network meta-analysis
Shulin Zhou, Yi Jiang, Chengyan Luo & Lin Yuan
Pages: 59-69
Published online: 04 Jan 2024
AbstractforComparison of poly (ADP-ribose) polymerase inhibitors (PARPis) as maintenance therapy for newly-diagnosed and platinum-sensitive recurrent ovarian cancer with BRCA mutational status: a systematic review and network meta-analysis | Full Text | References | PDF (2.5 MB) | EPUB
  • 335 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Safety and efficacy of Rucaparib in the treatment of ovarian cancer and patients with BRCA mutation: a systematic review and meta-analysis of phase III randomized clinical trials
Mus’ab Theeb Mustafa, Aws Khalid Abushanab, Mahmoud Taysir Mousa, Rana Ahmed Qawaqzeh, Hamza Muneer Alakhras, Ahmad Sami Othman & Ahmad Sa’ed
Pages: 71-79
Published online: 25 Jan 2024
AbstractforSafety and efficacy of Rucaparib in the treatment of ovarian cancer and patients with BRCA mutation: a systematic review and meta-analysis of phase III randomized clinical trials | Full Text | References | PDF (2.3 MB) | EPUB
  • 156 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
LncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis
Yufen Xu, Xiaoli Tan, Qi Yang, Zhixian Fang & Wenyu Chen
Pages: 81-93
Published online: 23 Jan 2024
AbstractforLncRNA HCG11 enhances the chemosensitivity of non-small cell lung cancer cells to Gemcitabine via miR-17-5p/p21 axis | Full Text | References | PDF (12 MB) | EPUB | Supplemental
  • 78 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Is the use of cetuximab in the first-line treatment of recurrent/metastatic head and neck cancer still important?
Pasquale Vitale et al.
Editorial | Published online: 13 May 2024
Free Access
The role of planetary health in urologic oncology
Laura Lawaczeck et al.
Review Article | Published online: 11 May 2024
Open Access
The PI3K signaling pathway; from normal lymphopoiesis to lymphoid malignancies
Bahareh Kashani et al.
Review Article | Published online: 8 May 2024
Is there a link between talcum powder, oxidative stress, and ovarian cancer risk?
Ghassan M. Saed
Comment | Published online: 8 May 2024
View all latest articles